Arteritic anterior ischemic optic neuropathy secondary to immune checkpoint inhibitors: A case report

Zahin Alam1, Tausif Ahmed Siddiqui2, Mohammed Usman Syed2

  • 1Department of Radiology, Hackensack Meridian School of Medicine, Nutley, NY, USA.

PubMed

Insights

This case report details a rare instance of arteritic anterior ischemic optic neuropathy (AAION) in a patient undergoing cancer therapy with immune checkpoint inhibitors (ICIs). It highlights the critical need for recognizing ICI-induced ocular complications and improving management strategies.

Area of Science:

  • Ophthalmology
  • Oncology
  • Neurology

Background:

  • Ischemic optic neuropathy (ION) results from reduced optic nerve blood supply, with anterior ischemic optic neuropathy (AION) often linked to giant cell arteritis (GCA).
  • Immune checkpoint inhibitors (ICIs) are used in cancer treatment and can cause neuro-ophthalmic immune-related adverse events (irAEs).

Observation:

  • A 77-year-old male with metastatic renal cell carcinoma on ICI therapy experienced bilateral vision loss.
  • Clinical presentation and MRI findings suggested GCA-associated AAION with orbital impact.

Findings:

  • The patient received corticosteroids, leading to immediate but incomplete visual recovery.
  • A temporal artery biopsy was nonconfirmatory, complicating the diagnosis.

Implications:

  • This case emphasizes the importance of clinical vigilance for ICI-associated ocular complications, particularly the rare AAION.
  • Challenges in diagnosing and managing ICI-induced AAION necessitate further research into effective treatment protocols to prevent permanent vision loss.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...